NEW YORK, Sept. 30 (GenomeWeb News) - Genome Therapeutics has raised approximately $9 million in net proceeds after expenses ($9.55 million total) through a private placement of common stock, the company said today.
...and receive Daily News bulletins.
Already have an account?Login Now.
Congress approved a bill Friday that would increase the US National Institutes of Health's funding by $2 billion for fiscal year 2019.
UK's Labour Party calls for a ban on non-invasive prenatal testing for determining sex, BBC News reports.
Sarah Lawrence College's Laura Hercher warns in a New York Times op-ed that more people are going to need help figuring out what their consumer genetic testing results mean.
In PLOS this week: intra-tumor heterogeneity patterns, genomic analysis of Thoroughbred horse origins, and more.